Ayad K. Ali

984 total citations
33 papers, 407 citations indexed

About

Ayad K. Ali is a scholar working on Toxicology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ayad K. Ali has authored 33 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Toxicology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ayad K. Ali's work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Asthma and respiratory diseases (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Ayad K. Ali is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (7 papers), Asthma and respiratory diseases (4 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Ayad K. Ali collaborates with scholars based in United States, United Kingdom and Finland. Ayad K. Ali's co-authors include Mahyar Etminan, Balraj S Heran, David E. Watson, Almut G. Winterstein, C.T. Klodell, Richard J. Johnson, Ahsan Ejaz, James A. Alexander, Thomas M. Beaver and Elaine Whidden and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Ayad K. Ali

32 papers receiving 392 citations

Peers

Countries citing papers authored by Ayad K. Ali

Since Specialization

Citations

This map shows the geographic impact of Ayad K. Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayad K. Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayad K. Ali more than expected).

Fields of papers citing papers by Ayad K. Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayad K. Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayad K. Ali. The network helps show where Ayad K. Ali may publish in the future.

Co-authorship network of co-authors of Ayad K. Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Ayad K. Ali. A scholar is included among the top collaborators of Ayad K. Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayad K. Ali. Ayad K. Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characteristics and outcomes of pregnancies in the Maternal Outcomes Masterset real‐world database 2023 ·Pharmacoepidemiology and Drug Safety ·(unknown), Ayad K. Ali, (unknown), (unknown), Reyna Klesh, (unknown), Elizabeth M. Garry	1
2	Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study 2022 ·BMJ Open ·Ashley Jaksa, (unknown), Seamus Kent, (unknown), Stephen Duffield, Manuj Sharma, (unknown), Ayad K. Ali, Amanda R. Patrick, (unknown), Páll Jónsson, Nicolle M. Gatto	11
3	Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study 2021 ·SHILAP Revista de lepidopterología ·Jianmin Wu, Fritha Morrison, Zhenxiang Zhao, (unknown), (unknown), Ayad K. Ali, Maria Shubina, Shervin Malmasi, Wendong Ge, Xiaomei Peng, Alexander Turchin	7
4	Incidence and Prevalence of Bile Duct and Gallbladder Disease in Patients with Diabetes in the U.S. 2018 ·Diabetes ·Ayad K. Ali, (unknown)	3
5	Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes 2017 ·Clinical Epidemiology ·Jason C. Simeone, Jay Bae, Byron J. Hoogwerf, Qian Li, Axel Haupt, Ayad K. Ali, Marilyn K. Boardman, Beth Nordstrom	27
6	Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs 2016 ·Journal of Managed Care & Specialty Pharmacy ·(unknown), Xiaomei Peng, Haoda Fu, Haya Ascher‐Svanum, Ángel Rodríguez, Ayad K. Ali, (unknown), (unknown), Anthony Louder	11
7	PHARMACOVIGILANCE TREND ANALYSIS OF MEDICATION ERRORS 2016 ·Value in Health ·Ayad K. Ali	1
8	Psychiatric Safety Profile Of Suvorexant, A First-In-Class Orexin Receptor Antagonist 2016 ·Value in Health ·Ayad K. Ali	1
9	Application of Multicategory Exposure Marginal Structural Models to Investigate the Association between Long-Acting Beta-Agonists and Prescribing of Oral Corticosteroids for Asthma Exacerbations in the Clinical Practice Research Datalink 2015 ·Value in Health ·Ayad K. Ali, Abraham G. Hartzema, Almut G. Winterstein, Richard Segal, Xiaomin Lu, Leslie Hendeles	8
10	The Link Between Proton Pump Inhibitors and Ischemic Heart Disease Could be Explained by Protopathic Bias: a Pharmacovigilance Analysis 2015 ·Value in Health ·Ayad K. Ali	2
11	Mirtazapine antidepressant therapy is associated with rhabdomyolysis risk 2014 ·Value in Health ·Ayad K. Ali	1
12	Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis 2014 ·Annals of Epidemiology ·Ayad K. Ali	46
13	Prescribing Long-Acting Beta-Agonists As Monotherapy To Adults With Controlled And Uncontrolled Asthma 2013 ·Value in Health ·Ayad K. Ali, Abraham G. Hartzema	1
14	Determinants of Prescribing Inhaled Long-Acting Beta-Agonist Bronchodilators As Monotherapy to Adults with Asthma 2013 ·Journal of Allergy and Clinical Immunology ·Ayad K. Ali	1
15	Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting 2012 ·Journal of Asthma and Allergy ·Ayad K. Ali	41
16	PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate: A Pharmacovigilance Analysis of the Adverse Event Reporting System 2012 ·Value in Health ·Ayad K. Ali	1
17	Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor 2011 ·Therapeutics and Clinical Risk Management ·Ayad K. Ali	25
18	The impact of off-pump coronary artery bypass surgery on postoperative renal function 2011 ·Perfusion ·Yasir Abu-Omar, (unknown), Manoraj Navaratnarajah, Ayad K. Ali, Ashwin Shahir, Ly‐Mee Yu, (unknown), (unknown)	9
19	Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery 2009 ·Journal of Thoracic and Cardiovascular Surgery ·Ahsan Ejaz, Tomas D. Martin, Richard J. Johnson, Almut G. Winterstein, C.T. Klodell, Philip J. Hess, Ayad K. Ali, Elaine Whidden, (unknown), James A. Alexander, (unknown), Thomas M. Beaver	42
20	10.51847/lLUqvBUBzF 2000 ·SHILAP Revista de lepidopterología ·Ayad K. Ali	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact